Management of Severe Angina Following Myocardial Infarction in a Patient with Comorbid Hypertension and Diabetes: A Case Report

Authors

  • Habib ur Razaq MTI-Hayatabad Medical Complex, Peshawar-Pakistan.

Keywords:

Myocardial Infarction, Angina, Percutaneous Coronary Intervention, Diabetes, Hypertension.

Abstract

Background: Managing severe angina in patients with comorbid conditions following a myocardial infarction poses significant clinical challenges. Optimal medical therapy often proves insufficient, necessitating advanced interventional strategies to address persistent symptoms and improve patient outcomes.

Case Presentation: A 50-year-old female with a history of hypertension and type 2 diabetes mellitus presented with severe angina classified as Canadian Cardiovascular Society (CCS) class II-III despite receiving optimal medical therapy after an inferior wall myocardial infarction treated with thrombolysis. Initial evaluations, including electrocardiogram (ECG) and echocardiography, indicated residual myocardial ischemia.

Results: Coronary angiography revealed moderate disease in the mid-left circumflex artery and severe tubular lesions in the mid-right coronary artery (RCA). Percutaneous coronary intervention (PCI) was performed on the RCA, involving the deployment of multiple drug-eluting stents. The procedure was complicated by a distal edge dissection and the breakage of a guide wire, both of which were successfully managed. Final angiographic results demonstrated TIMI III flow with no residual stenosis.

Conclusion: This case highlights the challenges and complexities of managing severe angina in post-myocardial infarction patients with comorbid conditions. It emphasizes the necessity of timely and precise interventional strategies to achieve optimal patient outcomes.

References

Babes EE, Bustea C, Behl T, Abdel-Daim MM, Nechifor AC, Stoicescu M, Brisc CM, Moisi M, Gitea D, Iovanovici DC, Bungau AF. Acute coronary syndromes in diabetic patients, outcome, revascularization, and antithrombotic therapy. Biomedicine & Pharmacotherapy. 2022;148:112772.

Davies A, Fox K, Galassi AR, Banai S, Ylä-Herttuala S, Luescher TF. Management of refractory angina: an update. Eur Heart J. 2021;42(3):269-283.

Manfredi R, Verdoia M, Compagnucci P, Barbarossa A, Stronati G, Casella M, Dello Russo A, Guerra F, Ciliberti G. Angina in 2022: Current perspectives. J Clin Med. 2022;11(23):6891.

Montone RA, Rinaldi R, Niccoli G, Andò G, Gragnano F, Piccolo R, Pelliccia F, Moscarella E, Zimarino M, Fabris E, de Rosa S. Optimizing Management of Stable Angina: A Patient-Centered Approach Integrating Revascularization, Medical Therapy, and Lifestyle Interventions. J Am Coll Cardiol. 2024;84(8):744-760.

Downloads

Published

2024-06-01

How to Cite

ur Razaq, H. (2024). Management of Severe Angina Following Myocardial Infarction in a Patient with Comorbid Hypertension and Diabetes: A Case Report . Cathalogue, 2(2), 75–80. Retrieved from http://pjcvi.com/index.php/Cathalogue/article/view/105

Issue

Section

Articles